IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-019-08464-y.html
   My bibliography  Save this article

The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model

Author

Listed:
  • Yang Liu

    (Chinese Academy of Sciences (CAS)
    Anhui University)

  • Yamin Gao

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

  • Jianxiong Liu

    (Guangzhou Chest Hospital)

  • Yaoju Tan

    (Guangzhou Chest Hospital)

  • Zhiyong Liu

    (Chinese Academy of Sciences (CAS))

  • Chiranjibi Chhotaray

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

  • Huofeng Jiang

    (Chinese Academy of Sciences (CAS)
    University of Science and Technology of China)

  • Zhili Lu

    (Chinese Academy of Sciences (CAS))

  • Gift Chiwala

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

  • Shuai Wang

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

  • Gaelle Makafe

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

  • Md Mahmudul Islam

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

  • H. M. Adnan Hameed

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

  • Xingshan Cai

    (Guangzhou Chest Hospital)

  • Changwei Wang

    (Chinese Academy of Sciences (CAS))

  • Xinjie Li

    (Guangzhou Chest Hospital)

  • Shouyong Tan

    (Guangzhou Chest Hospital)

  • Tianyu Zhang

    (Chinese Academy of Sciences (CAS)
    University of Chinese Academy of Sciences (UCAS))

Abstract

Buruli ulcer (BU) is an emerging infectious disease that causes disfiguring skin ulcers. The causative agent, Mycobacterium ulcerans, secretes toxin called mycolactone that triggers inflammation and immunopathology. Existing treatments are lengthy and consist of drugs developed for tuberculosis. Here, we report that a pyrazolo[1,5-a]pyridine-3-carboxamide, TB47, is highly bactericidal against M. ulcerans both in vitro and in vivo. In the validated mouse model of BU, TB47 alone reduces M. ulcerans burden in mouse footpads by more than 2.5 log10 CFU compared to the standard BU treatment regimen recommended by the WHO. We show that mutations of ubiquinol-cytochrome C reductase cytochrome subunit B confer resistance to TB47 and the dissimilarity of CydABs from different mycobacteria may account for their differences in susceptibility to TB47. TB47 is highly potent against M. ulcerans and possesses desirable pharmacological attributes and low toxicity that warrant further assessment of this agent for treatment of BU.

Suggested Citation

  • Yang Liu & Yamin Gao & Jianxiong Liu & Yaoju Tan & Zhiyong Liu & Chiranjibi Chhotaray & Huofeng Jiang & Zhili Lu & Gift Chiwala & Shuai Wang & Gaelle Makafe & Md Mahmudul Islam & H. M. Adnan Hameed & , 2019. "The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model," Nature Communications, Nature, vol. 10(1), pages 1-9, December.
    • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08464-y
    DOI: 10.1038/s41467-019-08464-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-08464-y
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-019-08464-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-08464-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.